It is worth mentioning that in some tumors, such as gastric and breast cancer, RUNX factors have a tumor suppressor activity through the formation of RUNX-YAP-TEAD complexes that reduce the transcription of YAP-TEAD target genes, thus abolishing YAP oncogenic activity [60,61]. This evidence concerns the gene YAP1 and breast cancer.